US Patent 7297703 Macrolides
Patent 7297703 was granted and assigned to Novartis on November, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+278 characters)
Article
Patent abstract
A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2, 6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07297703 Macrolides US Patent 7297703 Macrolides
Infobox
Patent Number
0729770300
Patent Number
729770300
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072977030
Date of Patent
November 20, 2007
0Patent Application Number
110208600
Date Filed
December 23, 2004
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072977030
Date of Patent
November 20, 2007
0Patent Application Number
110208600
Date Filed
December 23, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07297703 Macrolides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07297703
Date of patent
November 20, 2007
Patent application number
11020860
Date Filed
December 23, 2004
Patent primary examiner
Find more entities like US Patent 7297703 Macrolides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
